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An 86 year–old woman underwent routine decompression for carpal tunnel syndrome 
following which a sample of tenosynovium was examined histologically.  Amyloid deposits were 
identified on Congo red staining viewed under fluorescent light (A).  Immunohistochemical 
staining confirmed that the amyloid deposits were transthyretin (TTR) type.  She was referred 
to the National Amyloidosis Centre for further evaluation where she described a recent hospital 
admission for unexplained dyspnoea.  Echocardiography showed normal systolic function, but a 
thickened intraventricular septum along with impaired global strain rate of -15.7% and a strain 
pattern consistent with cardiac amyloidosis.  
99m
Technetium-3,3-diphosphono-1,2-
propanodicarboxylic acid (
99m
Tc–DPD) scintigraphy revealed Perugini grade 2 uptake of tracer in 
her heart (B).  Gene sequencing revealed no mutations in the transthyretin gene. A diagnosis of 
wild type ATTR amyloidosis (ATTRwt) was made.  
Carpal tunnel syndrome is a common early clinical manifestation of wild-type transthyretin 
amyloidosis, also known as senile systemic or cardiac amyloidosis.  Among patients with cardiac 
ATTRwt amyloidosis attending our centre, 98% have had evidence of median nerve entrapment 
on neurophysiological studies and 48% have had a history of carpal tunnel decompression as 
much as 12 years prior to their typical presentation with advanced heart failure symptoms.  
.
 
Cardiac ATTRwt amyloidosis is currently diagnosed in only about 150 individuals in the UK each 
year, but post-mortem studies indicate that ATTRwt amyloid deposits are actually present in up 
to 30% of males over 80 years (1).  Repurposing of 
99m
Tc-DPD bone scintigraphy largely 
abrogates the need for diagnostic cardiac biopsy, showing substantial cardiac uptake in nearly 
all cases (2). 
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Carpal tunnel biopsy can readily identify ATTR amyloid deposition and may identify individuals 
at risk of developing cardiac ATTR amyloidosis, for which specific therapies are now in clinical 
trial (3). 
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The word document contains the Title and legend as this is a clinical image for submission.  
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